|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
AU681396B2
(en)
*
|
1993-03-31 |
1997-08-28 |
G.D. Searle & Co. |
1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors
|
|
DE4427979A1
(de)
*
|
1993-11-15 |
1996-02-15 |
Cassella Ag |
Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
|
|
DK0730590T3
(da)
|
1993-11-24 |
2001-03-19 |
Du Pont Pharm Co |
Isoxazolin og isozazol fibrinogenreceptorantagonister
|
|
US5849736A
(en)
*
|
1993-11-24 |
1998-12-15 |
The Dupont Merck Pharmaceutical Company |
Isoxazoline and isoxazole fibrinogen receptor antagonists
|
|
DE19622489A1
(de)
*
|
1996-06-05 |
1997-12-11 |
Hoechst Ag |
Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters
|
|
US5981546A
(en)
*
|
1996-08-29 |
1999-11-09 |
Merck & Co., Inc. |
Integrin antagonists
|
|
WO1998016547A1
(en)
|
1996-10-11 |
1998-04-23 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
|
CA2268270A1
(en)
|
1996-10-11 |
1998-04-23 |
Cor Therapeutics, Inc. |
Heterocyclic derivatives as factor xa inhibitors
|
|
DE19751251A1
(de)
*
|
1997-11-19 |
1999-05-20 |
Hoechst Marion Roussel De Gmbh |
Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
|
|
US6645939B1
(en)
|
1997-11-24 |
2003-11-11 |
Merck & Co., Inc. |
Substituted β-alanine derivatives as cell adhesion inhibitors
|
|
MY153569A
(en)
|
1998-01-20 |
2015-02-27 |
Mitsubishi Tanabe Pharma Corp |
Inhibitors of ?4 mediated cell adhesion
|
|
DE19821483A1
(de)
*
|
1998-05-14 |
1999-11-18 |
Hoechst Marion Roussel De Gmbh |
Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
AU4584199A
(en)
*
|
1998-06-29 |
2000-01-17 |
Du Pont Pharmaceuticals Company |
Cyclic carbamates and isoxazolidines as iib/iiia antagonists
|
|
GB9826174D0
(en)
*
|
1998-11-30 |
1999-01-20 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
RU2255933C9
(ru)
*
|
1999-05-07 |
2005-11-20 |
Тексэс Байотекнолоджи Копэрейшн |
ПРОИЗВОДНЫЕ ПРОПИОНОВОЙ КИСЛОТЫ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ СЕЛЕКТИВНОГО ИНГИБИРОВАНИЯ СВЯЗЫВАНИЯ α4β1 ИНТЕГРИНА
|
|
US6723711B2
(en)
*
|
1999-05-07 |
2004-04-20 |
Texas Biotechnology Corporation |
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
|
|
US6972296B2
(en)
|
1999-05-07 |
2005-12-06 |
Encysive Pharmaceuticals Inc. |
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
|
|
ES2288871T3
(es)
|
1999-09-24 |
2008-02-01 |
Genentech, Inc. |
Derivados de tirosina.
|
|
DE10041423A1
(de)
|
2000-08-23 |
2002-03-07 |
Merck Patent Gmbh |
Biphenylderivate
|
|
DE10111876A1
(de)
*
|
2001-03-10 |
2002-09-19 |
Aventis Pharma Gmbh |
Bis(trifluormethyl)hydantoine als Zwischenprodukte für pharmazeutische Wirkstoffe
|
|
DE10154280A1
(de)
|
2001-11-05 |
2003-05-15 |
Wilex Ag |
Antagonisten für alpha¶4¶-Integrine
|
|
DK1485127T3
(da)
|
2002-02-25 |
2011-10-03 |
Elan Pharm Inc |
Anvendelse af midler til behandling af inflammation
|
|
WO2006026759A2
(en)
|
2004-09-03 |
2006-03-09 |
Genentech, Inc. |
Humanized anti-beta7 antagonists and uses therefor
|
|
EP1863940B1
(en)
|
2005-03-03 |
2012-06-06 |
Seedlings Life Science Ventures, LLC. |
Method of risk management for patients undergoing natalizumab treatment
|
|
WO2006126529A1
(ja)
|
2005-05-25 |
2006-11-30 |
Shionogi & Co., Ltd. |
６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
|
|
EA013080B1
(ru)
|
2005-06-09 |
2010-02-26 |
Юсб Фарма С.А. |
2,6-хинолинильные производные, способы их получения и их применение
|
|
US20070207141A1
(en)
|
2006-02-28 |
2007-09-06 |
Ivan Lieberburg |
Methods of treating inflammatory and autoimmune diseases with natalizumab
|
|
US20100272680A1
(en)
|
2009-02-09 |
2010-10-28 |
Subramanian Baskaran |
Piperidinyl Cyclic Amido Antiviral Agents
|
|
RU2016127812A
(ru)
|
2011-03-31 |
2018-12-06 |
Дженентек, Инк. |
Способы введения антагонистов интегрина бета7
|
|
PL2903691T3
(pl)
|
2012-10-05 |
2019-10-31 |
Hoffmann La Roche |
Sposoby diagnozowania i leczenia nieswoistego zapalenia jelit
|
|
WO2015148809A1
(en)
|
2014-03-27 |
2015-10-01 |
Genentech, Inc. |
Methods for diagnosing and treating inflammatory bowel disease
|
|
WO2016011940A1
(zh)
|
2014-07-25 |
2016-01-28 |
江苏恒瑞医药股份有限公司 |
氮茚-酰胺类衍生物、其制备方法及其在医药上的应用
|
|
HK1244229A1
(zh)
|
2015-02-26 |
2018-08-03 |
F. Hoffmann-La Roche Ag |
治疗CROHN病的整联蛋白β7拮抗剂和方法
|
|
US10246451B2
(en)
|
2017-04-26 |
2019-04-02 |
Aviara Pharmaceuticals, Inc. |
Propionic acid derivatives and methods of use thereof
|
|
EP3773573B1
(en)
|
2018-04-12 |
2026-03-18 |
Morphic Therapeutic, Inc. |
Antagonists of human integrin (alpha4)(beta7)
|
|
JP7189368B2
(ja)
|
2018-10-30 |
2022-12-13 |
ギリアード サイエンシーズ， インコーポレイテッド |
アルファ４ベータ７インテグリンの阻害のための化合物
|
|
ES3013256T3
(en)
|
2018-10-30 |
2025-04-11 |
Gilead Sciences Inc |
Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases
|
|
EP3873605B1
(en)
|
2018-10-30 |
2024-10-23 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha4beta7 integrin
|
|
FI3873884T3
(fi)
|
2018-10-30 |
2025-02-24 |
Gilead Sciences Inc |
3-(kinolin-8-yyli)-1,4-dihydropyrido[3,4-d]pyrimidiini-2,4-dionijohdannaisia alfa-4-beta-7-integriinin estäjinä tulehdussairauksien hoidossa
|
|
TWI775182B
(zh)
|
2019-10-16 |
2022-08-21 |
美商莫菲克醫療股份有限公司 |
抑制人類整合素αβ
|